Publications

Yomtoubian S, Lee SB, Verma A, Izzo F, Markowitz G, Choi H, Cerchietti L, Vahdat L, Brown KA, Andreopoulou E et al..  2020.  Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer.. Cell Rep. 30(3):755-770.e6.

Altorki NK, Markowitz GJ, Gao D, Port JL, Saxena A, Stiles B, McGraw T, Mittal V.  2019.  The lung microenvironment: an important regulator of tumour growth and metastasis.. Nat Rev Cancer. 19(1):9-31.

Stawowczyk M, Wellenstein MD, Lee SB, Yomtoubian S, Durrans A, Choi H, Narula N, Altorki NK, Gao D, Mittal V.  2017.  Matrix Metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor.. Neoplasia. 19(2):55-64.

Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong STC, Choi H, Rayes TEl, Ryu S, Troeger J et al..  2015.  Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.. Nature. 527(7579):472-6.

Gao D, Joshi N, Choi H, Ryu S, Hahn M, Catena R, Sadik H, Argani P, Wagner P, Vahdat LT et al..  2012.  Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition.. Cancer Res. 72(6):1384-94.

Gao D, Nolan D, McDonnell K, Vahdat L, Benezra R, Altorki N, Mittal V.  2009.  Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression.. Biochim Biophys Acta. 1796(1):33-40.

Gao D, Mittal V.  2009.  The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression.. Trends Mol Med. 15(8):333-43.